Stefan Michael Miller
Associate, Kirkland & Ellis LLP
With passage of the Leahy-Smith America Invents Act (AIA), new rules and procedures related to the application of prior art now apply to patenting under a â€œfirst-inventor-to-fileâ€ system. This article summarizes certain key prior art provisions that biotechnology companies should be aware of and details practical steps that can be implemented to help stake a competitive advantage under the new law including the use of patent liaisons, early provisional and patent application filings, and in certain circumstances, defensive publication of patentable subject matter.
Keywords:AIA ,patent ,prior art ,IP liaison ,en ,